Treatment of systemic vasculitis with cyclophosphamide and steroids: Daily oral low-dose cyclophosphamide administration after failure of a pulse intravenous high-dose regimen in four patients

Rheumatology

Volumn 33, Issue 10, 1994, Pages 959-962

  Genereau T ^a,c   Lortholary, O ^a,c   Leclerq, P ^a,c   Grenet, D ^b,c   Tubery M ^b,c   Sicard, D ^c,d   Caubarrere I ^b,c   Guillevin, L ^a,c  

^a AVICENNE HOSPITAL   (France)

^b Department of Pneumology ^*  (United Kingdom)

^c CHU RANGUEIL   (France)

^d NONE   (France)

Author keywords

Churg Strauss syndrome; Cyclophosphamide; Polyarteritis nodosa; Wegener's granulomatosis

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ADULT; AGED; ARTICLE; CASE REPORT; CHURG STRAUSS SYNDROME; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RELAPSE; REMISSION; VASCULITIS; WEGENER GRANULOMATOSIS;

ADMINISTRATION, ORAL; AGED; CHURG-STRAUSS SYNDROME; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGE; POLYARTERITIS NODOSA; PROSPECTIVE STUDIES; STEROIDS; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME; WEGENER'S GRANULOMATOSIS;

EID: 0028126831     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/33.10.959     Document Type: Article

References (22)

1. Kovarsky J. Ginical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic disease. Semin Arthritis Rheum 1983;12:359-72.
2. Nashel DJ. Mechanisms of action and clinical applications of cytotoxic drugs in rheumatic disorders. Med Clin North Am 1985;69:817-40.
3. Fauci AS, Katz P, Haynes BF, Wolff SM. Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N EnglJ Med 1979;301:235-8.
4. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener’s granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
5. Guillevin L, Jarrousse B, Lok C et al. Long-term follow- up after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparisons of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. J Rheumatol 1990;18:567-74.
6. Conn DL. Role of cyclophosphamide in treatment of polyarteritis nodosa. J Rheumatol 1991;18:489-90.
7. De Vita S, Neri R, Bombardieri S. Cyclophosphamide pulses in the treatment of rheumatic diseases: an update. Clin Exp Rheumatol 1991;9:179-93.
8. Austin HA, Klippel JH, Balow JE et al.Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986;314:614-9.
9. Cupps TR. Cyclophosphamide: to pulse or not to pulse? Am J Med 1990;89:399-402.
10. Guillevin L, Lê Thi Huong Du, Godeau P, Jais P, Wechsler B. Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients. BrJ Rheumatol 1988;27:258-64.
11. Guillevin L, Fain O, Lhote F, Jarrousse B, Le Thi Huong Du, Bussel A, Leon A. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. Arthritis Rheum 1992;35:208-15.
12. Lightfoot RW, Michel BA, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088-93.
13. Masi AT, Hunder GG, Lie JT et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33:1094-100.
14. Leavitt RA, Fauci AS, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis Arthritis Rheum 1990:23:1101-7.
15. Laing TJ. Gastrointestinal vasculitis and pneumatosis intestinalis due to systemic lupus erythematosis: successful treatment with pulse intravenous cyclophosphamide. Am J Med 1988;85:555-8.
16. Clements PJ, Davis J. Cytotoxic drugs: their clinical application to the rheumatic diseases. Semin Arthritis Rheum 1986;15:231-54.
17. Struck RF, Alberts DS, Home K, Philips JG, Peng YM, Roe DJ. Plasma pharmacokinetics of cyclophosphamide and its cytotoxic metabolites after intravenous versus oral administration in a randomized, crossover trial. Cancer Res 1987;47:2723-6.
18. Nishioka K, Katayama J, Sano S. Wegener’s granulomatosis: successful treatment with high-dose cyclophosphamide. Dermatologica 1982;164:142-7.
19. Fort JG, Abruzzo JL. Reversal of progressive necrotizing vasculitis with intravenous pulse cyclophosphamide and methylprednisolone. Arthritis Rheum 1988:21:1194-8.
20. Bacon PA. Vasculitis-clinical aspects and therapy. Acta Med Scand 1987;715 (Suppl.): 157-63.
21. Adu D, Luqmani RA, Richards N et al. Controlled trial of treatment of vasculitis. Clin Exp Immunol 1993;93(Suppl. 1):38.
22. Hoffman GS, Leavitt RY, Fleisher TA, Minor JR, Fauci AS. Treatment of Wegener’s granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med 1990;89:403-10.